Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Xaluritamig in Refractory Ewing Sarcoma: NCT07297979 Clinical Landscape Report 2026
18 September 2026
NCT07297979 clinical landscape for Refractory Ewing Sarcoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Poly ICLC in Triple Negative Breast Cancer: NCT07300475 Clinical Landscape Report 2026
18 September 2026
NCT07300475 clinical landscape for Triple Negative Breast Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Sacituzumab govitecan-hziy in Metastatic breast cancer: NCT07299409 Clinical Landscape Report 2026
18 September 2026
NCT07299409 clinical landscape for Metastatic breast cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Valemetostat Tosilate in Ovarian Cancer: NCT07303387 Clinical Landscape Report 2026
18 September 2026
NCT07303387 clinical landscape for Ovarian Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Pembrolizumab in Hodgkin's Lymphoma: NCT07302347 Clinical Landscape Report 2026
18 September 2026
NCT07302347 clinical landscape for Hodgkin's Lymphoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Lenalidomide in High grade B-cell lymphoma: NCT07308132 Clinical Landscape Report 2026
18 September 2026
NCT07308132 clinical landscape for High grade B-cell lymphoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Perflubutane in Breast Cancer: NCT07310758 Clinical Landscape Report 2026
18 September 2026
NCT07310758 clinical landscape for Breast Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
LM-103 in Uveal Melanoma: NCT07310784 Clinical Landscape Report 2026
18 September 2026
NCT07310784 clinical landscape for Uveal Melanoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
BI-3820768 in germ cell cancers: NCT07306559 Clinical Landscape Report 2026
18 September 2026
NCT07306559 clinical landscape for germ cell cancers: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
DPTX-3186 in Lung Cancer: NCT07312903 Clinical Landscape Report 2026
18 September 2026
NCT07312903 clinical landscape for Lung Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
CLR-121125 in Triple Negative Breast Cancer: NCT07311993 Clinical Landscape Report 2026
18 September 2026
NCT07311993 clinical landscape for Triple Negative Breast Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
BRY-812 in Female Genital Neoplasms: NCT07311538 Clinical Landscape Report 2026
18 September 2026
NCT07311538 clinical landscape for Female Genital Neoplasms: endpoints, sponsor, phase, geography, readouts, asset context and development white space.